Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Best Back-To-School tech recommendations from Kingston Technology Business
  • Life Journey of Akash Agarawal: “Kaisa Ho Hamara Sarpanch” Blog Writer & Founder of Kalamkunj Academy in Jaipur Business
  • Building Smarter Cities: The Future of Urban Growth Through Efficient Plan Approval Systems Business
  • Destination for All Your Astrology Needs: AstroApp Lifestyle
  • The future of PR is hybrid, says Bollywood PR expert Dale Bhagwagar in Masterclass at Pearl Academy Business
  • Manaksia Coated Metals & Industries Reports ₹790 Cr Total Income & ₹15 Cr Net Profit in FY25 Business
  • Asian Granito India Ltd reports Consolidated Net Sales of Rs. 384 crore in Q2FY25 Business
  • Terra Surfaces by Hafele Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Shalby Hospital Brings World-Class Orthopedic Care to Rajkot Health
  • Can Diabetic Retinopathy Be Reversed? Health
  • India Gets Its First-Ever, Comprehensive, Most Impactful Breast Cancer Program Health
  • Global Healthcare Academy Hosts Successful – Best of ASCO, Conference in Bengaluru Health
  • Nagpur Sets Milestone with First-Ever Triple Non-Surgical Heart Valve Replacements in a Single Day Health
  • Reasons You Were Prescribed CBC Test Health

Recent Posts

  • IIMSAM – United Nations ECOSOC Signs MoU with Big B Corporation and ADIMU, Kazakhstan to Advance Nutrition, Healthcare and Sustainable Development Initiatives
  • Supratiek Shyamal Ghosh: The Man Behind Aurko, The Vision Behind ALIVE INDIA
  • ACCE GLOBAL SOFTWARE PRIVATE LIMITED proudly announces the grand launch of KAVACH in Karnataka
  • Next 100x Gem: Why DigiTap Is Named Best Crypto Presale of 2026 as Ethereum and Solana Struggle for Momentum
  • DialNexa Analyzes 1 Million+ AI-Assisted Calls to Reveal What Makes Voice AI Work in India

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Inside Pan Oleo Energy’s Sustainable Biofuel Drive: Empowering Communities, Driving Change Business
  • CINELAL, the New OTT Platform is all set to Launch with Original Content by Mrs. Alankrit Rathod Entertainment
  • Unveiling the Year’s Most Provocative Cinematic Masterpiece: “The Diary of West Bengal” Produced by Jitendra Narayan Singh (Waseem Rizvi), Written And Directed by Sanoj Mishra Entertainment
  • DeepTek launches its new AI powered lumbar spine quantification automation tool “DeepSpine” at RSNA 2022 Business
  • BigBloc Construction Ltd recommends 1:1 Bonus Issue Business
  • Exeller Computer is a growing name for refurbished laptops in Delhi Business
  • Paawak Foods revolutionizing the jaggery market with its new and unique products, Small cubes Jaggery and with P technology Business
  • Who are the top 5 astrologers in India? Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme